Chime Biologics Expands Global Manufacturing Capacity with New GMP-2 Facility in Wuhan

 Chime Biologics’ manufacturing expansion builds on a decade of collaboration enabled by  Cytiva’s modular manufacturing platform&nbs...

June 09, 2026 | Tuesday | News
Pfizer’s Berobenatide Advances Toward Phase 3 as Potential First Monthly GLP-1 Therapy

Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in-class monthly GLP-1 receptor agon...

June 08, 2026 | Monday | News
SGS Acquires CMIC, INC. to Accelerate Growth in North America's Bioanalytical Testing Market

SGS, the world's leading testing, inspection and certification company, is pleased to announce that it has acquired CMIC, INC., a specialized provider of...

June 05, 2026 | Friday | News
Advanced NanoTherapies Secures $31 Million Series B to Advance Dual-Drug Balloon Platform for Vascular Disease

Advanced NanoTherapies, Inc. (ANT), a clinical-stage medtech company dedicated to improving outcomes for patients with coronary and peripheral artery dis...

June 04, 2026 | Thursday | News
Zymo Research Launches End-to-End NGS Services Portfolio to Accelerate Genomic Discovery

Zymo Research, a global leader in genomics tools, announced the launch of Zymo Services, a dedicated portfolio of end-to-end next-generation sequencing (...

June 04, 2026 | Thursday | News
First Foundation Labs and Microsoft Join Forces to Accelerate Life Sciences R&D with Enterprise AI

First Foundation Labs (1FL), a life sciences AI company pioneering clinical and translational reasoning spun out of Luma Group, announced a collaboration...

June 04, 2026 | Thursday | News
Amgen’s IMDYLLTRA Receives EU Approval for Extensive-Stage Small Cell Lung Cancer

Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction in Risk of Death with IMDYLLTRA Compared to Chemotherapy  Novel Treatment...

June 03, 2026 | Wednesday | News
Leica Biosystems Expands Collaboration with AstraZeneca and Daiichi Sankyo to Advance AI-Powered Biomarker Research in Lung Cancer

 Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, announced an expansion of its strat...

June 03, 2026 | Wednesday | News
IDT and Illumina Collaborate to Streamline End-to-End Oncology NGS Research Workflows

Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis ...

June 03, 2026 | Wednesday | News
T-CURX Acquires Pantherna to Accelerate In Vivo CAR-T Development

T-CURX leverages Pantherna’s deep expertise and proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovati...

June 03, 2026 | Wednesday | News
BioNTech And Bristol Myers Squibb Report Encouraging Phase 2 Data For Pumitamig In First Line NSCLC

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ch...

June 02, 2026 | Tuesday | News
Johnson & Johnson’s Apalutamide Regimen Cuts Metastasis Risk In High Risk Localised Prostate Cancer

Compared with patients receiving hormone therapy alone, patients were nine times more likely to havelittle to no cancer remaining in the prostate after s...

June 02, 2026 | Tuesday | News
Achieving the Promise of Biosimilars: Expanding Access, Affordability, and Healthcare Equity

As healthcare systems around the world grapple with rising costs, growing chronic disease burdens, and increasing demand for innovative therapies, biosimil...

June 01, 2026 | Monday | Interview
Why Basel Remains Europe’s Launchpad for Oncology Innovation and Global Biotech Growth

As biotech companies navigate increasingly complex pathways from scientific discovery to commercial success, the importance of location, expertise, and eco...

June 01, 2026 | Monday | Interview

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close